masoprocol has been researched along with Angiogenesis, Pathologic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bian, X; Chen, G; Cui, W; Cui, Y; Gu, A; Li, T; Xu, C; Yang, X; Yu, S; Zhang, X | 1 |
Bai, JS; Bian, XW; Chen, JH; Dai, C; Jiang, XF; Liu, MY; Lu, JY; Shi, JQ; Wang, JM; Wang, QL; Xin, R; Zhao, W | 1 |
Chen, Y; Guo, Y; Honn, KV; Jin, R; Krishnamoorthy, S; Milanini, J; Nie, D; Pages, G; Qiao, Y; Tang, K; Zacharek, A | 1 |
3 other study(ies) available for masoprocol and Angiogenesis, Pathologic
Article | Year |
---|---|
A synthetic dl-nordihydroguaiaretic acid (Nordy), inhibits angiogenesis, invasion and proliferation of glioma stem cells within a zebrafish xenotransplantation model.
Topics: AC133 Antigen; Animals; Antigens, CD; Antineoplastic Agents; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Glioma; Glycoproteins; Humans; Masoprocol; Neoplasm Invasiveness; Neoplastic Stem Cells; Neovascularization, Pathologic; Peptides; Receptors, Vascular Endothelial Growth Factor; Xenograft Model Antitumor Assays; Zebrafish | 2014 |
Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas.
Topics: Astrocytoma; Brain Neoplasms; Cell Line; Cells, Cultured; Endothelium, Vascular; Glioblastoma; Glioma; Humans; Immunomagnetic Separation; In Vitro Techniques; Lignans; Masoprocol; Microcirculation; Models, Biological; Neovascularization, Pathologic; Spheroids, Cellular; Vascular Endothelial Growth Factor A | 2006 |
Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Arachidonate 12-Lipoxygenase; Cell Line, Tumor; Cell Movement; Chromones; Endothelium, Vascular; Flavanones; Gene Expression Regulation, Neoplastic; Humans; Lipoxygenase Inhibitors; Male; Masoprocol; Morpholines; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Promoter Regions, Genetic; Prostatic Neoplasms; Vascular Endothelial Growth Factor A | 2006 |